Skip to main content
. 2021 Feb 13;25(2):101540. doi: 10.1016/j.bjid.2021.101540

Table 2.

Carbapenem susceptibility profile of Gram-negative HCAIs, in 24 hospitals with ICUs (2012–17).

Gram-negative SSI
Carb-S
RTI
Carb-S
BSI
Carb-S
UTI
Carb-S
N % N % N % N % N % N % N % N %
E. coli 608 20.7 594 97.7 261 5.2 259 99.2 424 12.4 409 96.5 1,621 33.3 1,603 98.9
K. pneumoniae 608 20.7 310 51.0 1,245 24.9 661 53.1 1,098 32.1 614 55.9 1,496 30.8 810 54.1
Enterobacter spp. 473 16.1 428 90.5 472 9.4 434 91.9 495 14.5 439 88.7 517 10.6 459 88.8
Other Enterobacterales 455 15.5 422 92.7 506 10.1 459 90.7 497 14.5 457 92.0 472 9.7 430 91.1
P. aeruginosa 497 17.0 418 84.1 1,437 28.7 932 64.9 463 13.5 315 68.0 611 12.6 423 69.2
A. baumannii 291 9.9 66 22.7 1,089 21.7 168 15.4 441 12.9 114 25.9 148 3.0 33 22.3



Total 2,932 100.0 2,238 76.3 5,010 100.0 2,913 58.1 3,418 100.0 2,348 68.7 4,865 100.0 3,758 77.2

HCAIs, healthcare-associated infections; BSI, bloodstream infection; RTI, respiratory tract infection; SSI, surgical site infection; UTI, urinary tract infection; Carb-S, carbapenem-susceptible; ICUs, intensive care units; N, number.